RGS.AX
Regeneus Ltd
Price:  
0.52 
AUD
Volume:  
8,674.00
Australia | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RGS.AX EV/EBITDA

-
Upside

As of 2025-07-08, the EV/EBITDA ratio of Regeneus Ltd (RGS.AX) is 1.01. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. RGS.AX's latest enterprise value is 4.75 mil AUD. RGS.AX's TTM EBITDA according to its financial statements is 4.71 mil AUD. Dividing these 2 quantities gives us the above RGS.AX EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative Enterprise Value.

Range Selected
Trailing P/E multiples - -
Forward P/E multiples - -
Fair Price - -
Upside - -
0.52 AUD
Stock Price
- AUD
Fair Price

RGS.AX EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA